Address:
18 Komsomolskaya Street, Dubrovno, Vitebsk Oblast, 211587
Phone:
8 (02137) 5-45-01
Fax:
8 (02137) 5-45-25
E-mail:
dubrovno_rik@vitobl.by
It is noted that the updated vaccine underwent clinical trials, during which it showed a favorable safety and immunogenicity profile, and a low incidence of significant side effects.
The press service added that state quality control of the first drugs in the laboratories of Roszdravnadzor is being completed. Registration will allow the vaccine manufacturer to introduce it into civilian circulation and begin deliveries according to regional orders.